These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 34623772

  • 1. Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy.
    Badina L, Belluzzi B, Contorno S, Bossini B, Benelli E, Barbi E, Berti I.
    Immun Inflamm Dis; 2022 Jan; 10(1):117-120. PubMed ID: 34623772
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of omalizumab-assisted desensitisation to cow's milk and eggs in patients refractory to conventional oral immunotherapy: real-life study.
    Ayats-Vidal R, Riera-Rubió S, Valdesoiro-Navarrete L, García-González M, Larramona-Carrera H, Cruz OA, Bosque-García M.
    Allergol Immunopathol (Madr); 2022 Jan; 50(3):1-7. PubMed ID: 35527650
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.
    Wood RA, Kim JS, Lindblad R, Nadeau K, Henning AK, Dawson P, Plaut M, Sampson HA.
    J Allergy Clin Immunol; 2016 Apr; 137(4):1103-1110.e11. PubMed ID: 26581915
    [Abstract] [Full Text] [Related]

  • 4. Identification of novel peptide biomarkers to predict safety and efficacy of cow's milk oral immunotherapy by peptide microarray.
    Martínez-Botas J, Rodríguez-Álvarez M, Cerecedo I, Vlaicu C, Diéguez MC, Gómez-Coronado D, Fernández-Rivas M, de la Hoz B.
    Clin Exp Allergy; 2015 Jun; 45(6):1071-84. PubMed ID: 25772539
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy for cow's milk allergy.
    Taniuchi S, Takahashi M, Soejima K, Hatano Y, Minami H.
    Hum Vaccin Immunother; 2017 Oct 03; 13(10):2443-2451. PubMed ID: 28825866
    [Abstract] [Full Text] [Related]

  • 6. Benefits of baked milk oral immunotherapy in French children with cow's milk allergy.
    Gruzelle V, Juchet A, Martin-Blondel A, Michelet M, Chabbert-Broue A, Didier A.
    Pediatr Allergy Immunol; 2020 May 03; 31(4):364-370. PubMed ID: 31943363
    [Abstract] [Full Text] [Related]

  • 7. High IgE levels to α-lactalbumin, β-lactoglobulin and casein predict less successful cow's milk oral immunotherapy.
    Kuitunen M, Englund H, Remes S, Movérare R, Pelkonen A, Borres MP, Mäkelä MJ.
    Allergy; 2015 Aug 03; 70(8):955-62. PubMed ID: 25951431
    [Abstract] [Full Text] [Related]

  • 8. Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial.
    Takahashi M, Soejima K, Taniuchi S, Hatano Y, Yamanouchi S, Ishikawa H, Irahara M, Sasaki Y, Kido H, Kaneko K.
    Sci Rep; 2017 Dec 12; 7(1):17453. PubMed ID: 29234055
    [Abstract] [Full Text] [Related]

  • 9. Successful oral desensitization in children with cow's milk anaphylaxis: Clinical and laboratory evaluation up to nine-years follow-up.
    Alves-Correia M, Gaspar Â, Borrego LM, Azevedo J, Martins C, Morais-Almeida M.
    Allergol Immunopathol (Madr); 2019 Dec 12; 47(2):133-140. PubMed ID: 30482599
    [Abstract] [Full Text] [Related]

  • 10. Cow's Milk Desensitization in Anaphylactic Patients: A New Personalized-dose Method.
    Babaie D, Nabavi M, Arshi S, Mesdaghi M, Chavoshzadeh Z, Bemanian MH, Tafakori M, Amirmoini M, Esmailzadeh H, Molatefi R, Rekabi M, Akbarpour N, Masoumi F, Fallahpour M.
    Iran J Allergy Asthma Immunol; 2017 Feb 12; 16(1):45-52. PubMed ID: 28417624
    [Abstract] [Full Text] [Related]

  • 11. Could Age and Oral Challenge Outcomes Identify High-Risk Patients During Cow's Milk Oral Immunotherapy?
    Duman Senol H, Topyildiz E, Ulusoy Severcan E, Eren Akercan S, Cigerci Gunaydin N, Gulen F, Demir E.
    Pediatr Allergy Immunol Pulmonol; 2022 Jun 12; 35(2):95-101. PubMed ID: 35675663
    [Abstract] [Full Text] [Related]

  • 12. Oral immunotherapy in severe cow's milk allergic patients treated with omalizumab: Real life survey from a Spanish registry.
    Ibáñez-Sandín MD, Escudero C, Candón Morillo R, Lasa EM, Marchán-Martín E, Sánchez-García S, Terrados S, González Díaz C, Juste S, Martorell A, Gázquez García V, Ramírez Jiménez A, Abellán Á, Martos Calahorro MD, Tabar AI, Bartra J, García Rodríguez R, Gómez Galán C, Martín-Muñoz MF, Meseguer Arce J, Miralles JC, Montoro de Francisco AM, Poza Guedes P, Rodríguez Del Río P, OmaBASE task force (Pediatric Allergy Committee, Spanish Society of Allergy and Clinical Immunology).
    Pediatr Allergy Immunol; 2021 Aug 12; 32(6):1287-1295. PubMed ID: 33835593
    [Abstract] [Full Text] [Related]

  • 13. Changes in biomarkers during a six-month oral immunotherapy intervention for cow's milk allergy.
    Salmivesi S, Paassilta M, Huhtala H, Nieminen R, Moilanen E, Korppi M.
    Acta Paediatr; 2016 Nov 12; 105(11):1349-1354. PubMed ID: 27537244
    [Abstract] [Full Text] [Related]

  • 14. Early introduction oral immunotherapy for IgE-mediated cow's milk allergy: A follow-up study confirms this approach as safe and appealing to parents.
    Badina L, Levantino L, Carrato V, Peruch G, Celsi F, Barbi E, Berti I, Longo G.
    Immun Inflamm Dis; 2021 Sep 12; 9(3):918-922. PubMed ID: 34002933
    [Abstract] [Full Text] [Related]

  • 15. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
    Frischmeyer-Guerrerio PA, Masilamani M, Gu W, Brittain E, Wood R, Kim J, Nadeau K, Jarvinen KM, Grishin A, Lindblad R, Sampson HA.
    J Allergy Clin Immunol; 2017 Oct 12; 140(4):1043-1053.e8. PubMed ID: 28414061
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
    Yee CSK, Albuhairi S, Noh E, El-Khoury K, Rezaei S, Abdel-Gadir A, Umetsu DT, Burke-Roberts E, LeBovidge J, Schneider L, Rachid R.
    J Allergy Clin Immunol Pract; 2019 Feb 12; 7(2):451-461.e7. PubMed ID: 30267889
    [Abstract] [Full Text] [Related]

  • 17. Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis.
    Zuberbier T, Wood RA, Bindslev-Jensen C, Fiocchi A, Chinthrajah RS, Worm M, Deschildre A, Fernandez-Rivas M, Santos AF, Jaumont X, Tassinari P.
    J Allergy Clin Immunol Pract; 2023 Apr 12; 11(4):1134-1146. PubMed ID: 36529441
    [Abstract] [Full Text] [Related]

  • 18. Oral Immunotherapy for Food Allergy.
    Wood RA.
    J Investig Allergol Clin Immunol; 2017 Apr 12; 27(3):151-159. PubMed ID: 28102823
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of baked milk oral immunotherapy in baked milk-reactive allergic patients.
    Goldberg MR, Nachshon L, Appel MY, Elizur A, Levy MB, Eisenberg E, Sampson HA, Katz Y.
    J Allergy Clin Immunol; 2015 Dec 12; 136(6):1601-1606. PubMed ID: 26194541
    [Abstract] [Full Text] [Related]

  • 20. Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy.
    Savilahti EM, Kuitunen M, Valori M, Rantanen V, Bardina L, Gimenez G, Mäkelä MJ, Hautaniemi S, Savilahti E, Sampson HA.
    Pediatr Allergy Immunol; 2014 May 12; 25(3):227-35. PubMed ID: 24393339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.